20 May 2013
Keywords: ec, approves, expanded, indication, velcade, health, care
Article | 15 September 2008
US health care major Johnson & Johnson's multiple myeloma drug Velcade (bortezomib) has been approved by the European Commission for use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 September 2008
22 September 2008
17 May 2013
© 2013 thepharmaletter.com